Feature | May 26, 2015

Mitralign Presents Six-Month Data on Mitral Percutaneous Annuloplasty System at EuroPCR 2015

Company seeking CE mark for mitral/tricuspid repair valve in 2015

May 26, 2015 — At EuroPCR 2015, Mitralign presented updates on its mitral and tricuspid valve repair systems, including a presentation on six-month data on its Mitral system.

The Mitralign Percutaneous Annuloplasty System (MPAS) is not approved for sale or distribution; however it is currently being evaluated in clinical trials for a CE mark indication. The MPAS for tricuspid regurgitation is not approved for sale or distribution, but is anticipated to begin clinical investigation in 2015.

Updates on Mitralign’s percutaneous programs were available in the following presentations:

  • Transcatheter mitral valve therapies; new rings, anchors, and techniques;
  • First-in-man of a transcatheter tricuspid valve in a severely regurgitant tricuspid valve patient;
  • Mitralign procedure: A step-by-step case demonstration; and
  • Cardiovascular innovation pipeline – Mitral and tricuspid valve intervention.

 

Georg Nickenig, M.D., presented “Mitralign CE mark six month data” during the Mitralign Symposium, chaired by Azeem Latib, M.D., and Ted Feldman, M.D. Nickenig was joined by Joachim Schofer, M.D., and Rebecca Hahn, M.D., providing their experience with the Mitralign Percutaneous Annuloplasty System for tricuspid regurgitation.

Unlike other approaches, the Mitralign Percutaneous Annuloplasty System uses wires and catheters to deliver pledgets to create plications and tighten the annulus, reduce valve circumference and bring the leaflets closer together.

For more information: www.mitralign.com

Related Content

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init